Delivery Order SPE2DB24D9223-SPE2DB25FKEKD
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $6,697.06 by the Defense Logistics Agency (DLA) on August 25, 2025, for the supply of Nplate 500 microgram vials. This firm fixed-price delivery order is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500 million vehicle valid through November 2026 that enables the agency to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $20,091.18 by the Defense Logistics Agency (DLA) on September 8, 2025. The delivery order, which is not subject to a set-aside designation, calls for the supply of Nplate 500 microgram vials with an ultimate completion date of September 29, 2025. This award is issued under DMS Pharmaceutical Group's existing Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $13,389.36 by the Defense Logistics Agency (DLA) on June 2, 2025, for the supply of Nplate 250 micrograms vials. The contract represents a firm fixed-price delivery order with an ultimate completion date of June 24, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $6,694.68 by the Defense Logistics Agency on July 29, 2025, for the supply of Nplate 250 microgram vials. The award carries an ultimate completion date of August 19, 2025, and was issued without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,347.34 by the Defense Logistics Agency on July 31, 2025, for the supply of Nplate 250 microgram vials. The delivery order carries an ultimate completion date of August 21, 2025, and requires performance at the contractor's Park Ridge, Illinois facility. This award was issued without a set-aside designation, allowing DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,366.20 by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of Nplate 125 microgram vials. This firm fixed-price delivery order, which carries an ultimate completion date of September 23, 2025, is issued without a set-aside designation and represents a continuation of the company's substantial partnership with DLA....
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on September 10, 2025, for the supply of Nplate 250 microgram vials. The contract, valued at $16,736.70, carries a firm fixed-price structure with an ultimate completion date of October 1, 2025. This delivery order was issued without a set-aside designation and is funded through the Defense Logistics Agency's Medical Supply Chain division, reflecting...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,366.20 by the Defense Logistics Agency on September 2, 2025, for the supply of Nplate 125 microgram vials. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and extending through November 2026. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $33.5K for 500 microgram vials of Nplate by the Defense Logistics Agency's Medical Supply Chain. The award, issued on September 9, 2025, is a firm fixed-price delivery order with an ultimate completion date of September 30, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $13,389.36 to DMS Pharmaceutical Group Inc. for the supply of Nplate 250 microgram vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this order at its facility in Park Ridge, IL, with an ultimate completion date of August 11, 2025. The award was issued on July 21, 2025, and does not include a set-aside designation, allowing the...
- SPE2DB24D9223Indefinite Delivery Contract
- SPE2DB24D9223-SPE2DB25FKEKDDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $6,697.06 by the Defense Logistics Agency (DLA) on August 12, 2025, for the supply of Nplate 500 microgram vials. The contract does not utilize a set-aside designation and carries an ultimate completion date of September 3, 2025. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, which is valued at $499,999,999 and remains valid through November 2026. The award represents a continuation of DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain, specifically supporting the Department of Defense healthcare systems. Nplate (romiplostim) is an injectable medication used to treat thrombocytopenia, and its procurement through DLA ensures adequate pharmaceutical inventory across military health facilities. The delivery order maintains the firm fixed-price structure consistent with DMS Pharmaceutical Group's standard contracting approach with the DLA, enabling efficient distribution of branded and generic prescription drugs, biologics, and specialized pharmaceutical products to military healthcare providers nationwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 8/12/25 |